This project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement N° 730964.

Designed by European Vaccine Initiative

Services do NOT include

Enhanced analysis (ICS, luminex, neutralisation assays), challenge studies.

Possible Output

Project management, raw data for clinical follow-up, tolerability assessment, CBC, blood chemistry, antibody binding and ELISPOT, cryopreserved plasma, serum, mucosal fluids and cells.

Sample Requirements - input of users

Immunogen and adjuvant - if any - with specification datasheets.

Lead Scientist

Raphael Ho Tsong Fang

Description of service

Immunogenicity study (1 NHP)


6 months (max), depending on the immunisation schedule


Raphael Ho Tsong Fang


Paid Service